Literature DB >> 15867344

Implication of galectin-3 in Wnt signaling.

Tatsuo Shimura1, Yukinori Takenaka, Tomoharu Fukumori, Soichi Tsutsumi, Kohji Okada, Victor Hogan, Akira Kikuchi, Hiroyuki Kuwano, Avraham Raz.   

Abstract

Galectin-3 (gal-3), a member of the beta-galactoside-binding proteins family, was identified as a binding partner of beta-catenin. Analysis of the human gal-3 sequence reveled a structural similarity to beta-catenin as it also contains the consensus sequence (S92XXXS96) for glycogen synthase kinase-3beta (GSK-3beta) phosphorylation and can serve as its substrate. In addition, Axin, a regulator protein of Wnt that complexes with beta-catenin, also binds gal-3 using the same sequence motif identified here by a deletion mutant analysis. The data presented here give credence to the suggestion that gal-3 is a key regulator in the Wnt/beta-catenin signaling pathway and highlight the functional similarities between gal-3 and beta-catenin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15867344     DOI: 10.1158/0008-5472.CAN-05-0104

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

Review 1.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

Review 2.  Galectin-3 and cancer stemness.

Authors:  Pratima Nangia-Makker; Victor Hogan; Avraham Raz
Journal:  Glycobiology       Date:  2018-04-01       Impact factor: 4.313

Review 3.  Nuclear transport of galectin-3 and its therapeutic implications.

Authors:  Tatsuyoshi Funasaka; Avraham Raz; Pratima Nangia-Makker
Journal:  Semin Cancer Biol       Date:  2014-03-19       Impact factor: 15.707

4.  Role of MSC-derived galectin 3 in the AML microenvironment.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Jared K Burks; YiHua Qiu; Rui-Yu Wang; Elizabeth J Shpall; Leonardo Mirandola; Numsen Hail; Zhihong Zeng; Teresa McQueen; Naval Daver; Sean M Post; Maurizio Chiriva-Internati; Steven M Kornblau; Michael Andreeff
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-04-12       Impact factor: 4.739

Review 5.  Galectin-3 and the skin.

Authors:  Larissa Larsen; Huan-Yuan Chen; Jun Saegusa; Fu-Tong Liu
Journal:  J Dermatol Sci       Date:  2011-08-11       Impact factor: 4.563

6.  Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity.

Authors:  Gordana Radosavljevic; Ivan Jovanovic; Ivana Majstorovic; Maja Mitrovic; Vanda Juranic Lisnic; Nebojsa Arsenijevic; Stipan Jonjic; Miodrag L Lukic
Journal:  Clin Exp Metastasis       Date:  2011-03-26       Impact factor: 5.150

7.  Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.

Authors:  Tsutomu Kobayashi; Tatsuo Shimura; Toshiki Yajima; Norio Kubo; Kenichiro Araki; Soichi Tsutsumi; Hideki Suzuki; Hiroyuki Kuwano; Avraham Raz
Journal:  Int J Cancer       Date:  2011-03-29       Impact factor: 7.396

Review 8.  Extracellular heparan sulfate proteoglycans and glycan-binding lectins orchestrate trans-synaptic signaling.

Authors:  Emma Rushton; Danielle L Kopke; Kendal Broadie
Journal:  J Cell Sci       Date:  2020-08-11       Impact factor: 5.285

9.  Expression of APC protein during tongue malignant transformation in galectin-3-deficient mice challenged by the carcinogen 4-nitroquniline-n-oxide.

Authors:  Marcus Vinicius Rodrigues de Souza; João Paulo Silva Servato; Adriano Mota Loyola; Sérgio Vitorino Cardoso; Roger Chammas; Fu-Tong Liu; Marcelo José Barbosa Silva; Paulo Rogério de Faria
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

10.  Proteome serological determination of tumor-associated antigens in melanoma.

Authors:  Michael Forgber; Uwe Trefzer; Wolfram Sterry; Peter Walden
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.